cjc 1295 ipamorelin injection site reaction CJC-1295 / Peptide Injections cjc 1295 ipamorelin injection site

CJC-1295 Also known as: CJC-1295 DAC, Modified GRF 1-29, Drug Affinity Complex Summary CJC-1295 is a synthetic GHRH analog engineered to resist enzymatic breakdown, existing in two forms with dramatically different durations days with the DAC modification, ~30 minutes without (Mod GRF 1-29)

Testing is available, but the symptoms of depletion (fatigue, brain fog, frequent illness, slow recovery) are common enough that most adults benefit from support

Synthesized via SPPS and HPLC-purified

Administration Protocol Typically administered once daily, with doses ranging from 20-100mcg based on individual factors, goals, and provider recommendations